hexanoic acid has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ancuta, P; Baril, JG; Boldeanu, I; Bunet, R; Chamberland, A; Chartrand-Lefebvre, C; Chomont, N; Durand, M; El-Far, M; Filali-Mouhim, A; French, AL; Gange, SJ; Gonzalez, E; Goulet, JP; Hanna, DB; Kaplan, RC; Karim, R; Kassaye, S; Kizer, JR; Landay, AL; Larouche-Anctil, E; Lesage, S; Martinson, JA; Ramani, H; Routy, JP; Sadouni, M; Sylla, M; Thomas, R; Tremblay, CL; Trottier, B; Turcotte, I; Zaidan, S | 1 |
1 other study(ies) available for hexanoic acid and HIV Coinfection
| Article | Year |
|---|---|
Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Caproates; Electrocardiography; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Gene Expression Regulation; HIV Infections; Humans; Interleukins; Macrophages; Male; Metagenome; Metagenomics; Monocytes; T-Lymphocytes; Tomography, X-Ray Computed | 2021 |